|
LOC646214 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.39920000030713E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.0516999998943E-07 |
| Normal-vs-Stage2 |
2.13570000018315E-07 |
| Normal-vs-Stage3 |
9.79950000035146E-08 |
| Normal-vs-Stage4 |
5.85169999999247E-05 |
| Stage1-vs-Stage2 |
6.108600E-01 |
| Stage1-vs-Stage3 |
5.238200E-01 |
| Stage1-vs-Stage4 |
7.868400E-01 |
| Stage2-vs-Stage3 |
9.650800E-01 |
| Stage2-vs-Stage4 |
5.806400E-01 |
| Stage3-vs-Stage4 |
5.738400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8216999997378E-07 |
| Normal-vs-AfricanAmerican |
7.034000E-04 |
| Normal-vs-Asian |
6.90439999950776E-07 |
| Caucasian-vs-AfricanAmerican |
1.448980E-01 |
| Caucasian-vs-Asian |
9.022800E-01 |
| AfricanAmerican-vs-Asian |
1.529810E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.33759999998428E-06 |
| Normal-vs-Female |
9.25480000413259E-08 |
| Male-vs-Female |
3.972400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.50349999952881E-07 |
| Normal-vs-Age(41-60Yrs) |
1.63850000012289E-07 |
| Normal-vs-Age(61-80Yrs) |
9.36429999986998E-07 |
| Normal-vs-Age(81-100Yrs) |
2.59430000004723E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.727800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.917400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.623200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.558800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.635600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.743600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.502230E-01 |
| Classical-VS-Follicular |
6.364600E-01 |
| Classical-VS-Other |
9.267000E-01 |
| Classical-VS-Normal |
3.99789999994127E-07 |
| Tall-VS-Follicular |
1.288380E-01 |
| Tall-VS-Other |
7.065200E-01 |
| Tall-VS-Normal |
6.82359999615301E-08 |
| Follicular-VS-Other |
8.113000E-01 |
| Follicular-VS-Normal |
2.1658000000091E-06 |
| Other-VS-Normal |
3.232200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.09759999977754E-07 |
| Normal-vs-N1 |
2.29629999999315E-05 |
| N0-vs-N1 |
7.513000E-01 |
|
|
